Table 1 Demographical and clinicopathological characteristics of all the participants
Parameters | PDAC group (N = 72) | Healthy control group (N = 136) | P value |
|---|---|---|---|
Age, average ± standard error | 59.54 ± 1.19 | 58.23 ± 0.75 | 0.379 |
Gender, n (%) | |||
 Male | 41(57%) | 48(35%) | 0.003 |
BMI, average ± standard error | 22.03 ± 0.37 | 23.81 ± 0.30 | < 0.0001 |
Smoking history, n (%) | 22(31%) | 19(14%) | 0.004 |
Alcohol history, n (%) | 25(35%) | 19(14%) | < 0.0001 |
Chronic disease, n (%) | |||
 Hypertension | 9(13%) | 37(27%) | 0.015 |
 Type II diabetes | 13(18%) | 15(11%) | 0.158 |
CA199, average ± standard error | 357.29 ± 42.28 | / |  |
Jaundice | 21(29%) | 0 | < 0.0001 |
Tumor size, average ± standard error | 3.79 ± 0.19 | / |  |
Primary cancer site, n (%) | Â | / | Â |
 Uncinate process | 13(18%) |  |  |
 Head | 29(40%) |  |  |
 Body | 17(24%) |  |  |
 Tail | 13(18%) |  |  |
Surgery, n (%) | Â | / | Â |
 Pancreaticoduodenectomy | 26(36%) |  |  |
 Distal pancreatectomy | 11(15%) |  |  |
 Palliative intervention techniques | 35(49%) |  |  |
AJCC staging, n (%) | Â | / | Â |
 I | 8(11%) |  |  |
 II | 28(39%) |  |  |
 III | 18(25%) |  |  |
 IV | 18(25%) |  |  |